# BD to acquire Edwards Lifesciences' Critical Care for $4.2B

BD (Becton, Dickinson and Company) has signed a definitive agreement to acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. Critical Care is a leader in advanced patient monitoring solutions.

- Type: Acquisition
- Announced: 2024-06-03
- Where: Irvine, California, USA, United States
- Value: $4.20B
- Jobs: 4,500
- Status: announced
- Products: advanced patient monitoring solutions, hemodynamic monitoring, AI-enabled clinical decision tools
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (target)
- [Becton, Dickinson and Company (BD)](https://endata.com/companies/77803.md) (acquirer)

## Sources

- [news.bd.com](https://news.bd.com/2024-06-03-BD-to-Acquire-Edwards-Lifesciences-Critical-Care-Product-Group-for-4-2-Billion-to-Expand-Smart-Connected-Care-Solutions-and-Become-an-Advanced-Monitoring-Technology-Leader), 2024-06-03: "BD will acquire Edwards' Critical Care product group for $4.2 billion in cash"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.